For individuals with diabetes mellitus, one of the most common chronic conditions involves diabetic peripheral neuropathy (DPN), a type of nerve damage that causes pain, numbness, and sensory or motor dysfunction in almost 50% of all patients 1
In a clinical trial called SURMOUNT-5, people who used Zepbound over 72 weeks lost 20.2% of their body weight, compared to 13.7% in people who used Wegovy
First, almost every included study did not consider thyroid events as the main result, only regarded them as safety results and did not monitor the changes in thyroid function at the same time
According to a narrative review done in 2025, it was originally isolated from human gastric juice by Dr
At the same time, stopping semaglutide doesnt guarantee reversal